Local administration of an IL-2-expressing vaccinia virus (VV-IL-2) significantly reduced tumor burden, due to the increase in the activity of immune cells including CD4+ and CD8+ T cells and α,β T-cell receptor diversity in a malignant pleural disease model (Figure 11). This evidence concerns the gene CD4 and neoplasm.